{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:39:38Z","timestamp":1777030778038,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10787-021-00896-7","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T10:02:58Z","timestamp":1637834578000},"page":"343-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["NSAIDs and Kelleni\u2019s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-6025","authenticated-orcid":false,"given":"Mina T.","family":"Kelleni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"896_CR1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.pcl.2017.08.009","volume":"64","author":"JV Aranda","year":"2017","unstructured":"Aranda JV, Salomone F, Valencia GB, Beharry KD (2017) Non-steroidal anti-inflammatory drugs in newborns and infants. Pediatr Clin North Am 64:1327\u20131340","journal-title":"Pediatr Clin North Am"},{"key":"896_CR2","doi-asserted-by":"crossref","first-page":"117842","DOI":"10.1016\/j.lfs.2020.117842","volume":"255","author":"A Banerjee","year":"2020","unstructured":"Banerjee A, Czinn SJ, Reiter RJ, Blanchard TG (2020) Crosstalk between endoplasmic reticulum stress and anti-viral activities: a novel therapeutic target for COVID-19. Life Sci 255:117842","journal-title":"Life Sci"},{"key":"896_CR3","doi-asserted-by":"crossref","first-page":"100981","DOI":"10.1016\/j.eclinm.2021.100981","volume":"37","author":"VF Blum","year":"2021","unstructured":"Blum VF, Cimerman S, Hunter JR, Tierno P, Lacerda A, Soeiro A et al (2021) Nitazoxanide superiority to placebo to treat moderate COVID-19: a pilot prove of concept randomized double-blind clinical trial. EClinicalMedicine 37:100981","journal-title":"EClinicalMedicine"},{"key":"896_CR4","doi-asserted-by":"crossref","first-page":"100915","DOI":"10.1016\/j.nmni.2021.100915","volume":"43","author":"FA Cadegiani","year":"2021","unstructured":"Cadegiani FA, Goren A, Wambier CG, McCoy J (2021) Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients. New Microbes New Infect 43:100915","journal-title":"New Microbes New Infect"},{"key":"896_CR5","doi-asserted-by":"crossref","first-page":"105297","DOI":"10.1016\/j.phrs.2020.105297","volume":"163","author":"L Cao","year":"2021","unstructured":"Cao L, Mu W (2021) Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacol Res 163:105297\u2013105297","journal-title":"Pharmacol Res"},{"key":"896_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.24.312769","author":"JS Chen","year":"2020","unstructured":"Chen JS, Alfajaro MM, Wei J, Chow RD, Filler RB, Eisenbarth SC et al (2020) Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication. bioRxiv. https:\/\/doi.org\/10.1101\/2020.09.24.312769","journal-title":"bioRxiv"},{"issue":"4","key":"896_CR7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1213\/ANE.0000000000005292","volume":"132","author":"JH Chow","year":"2021","unstructured":"Chow JH, Khanna AK, Kethireddy S, Yamane D, Levine A, Jackson AM et al (2021) Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg 132(4):930\u2013941","journal-title":"Anesth Analg"},{"key":"896_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/molecules25010063","volume":"25","author":"E Cione","year":"2020","unstructured":"Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P, Gallelli L et al (2020) Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA Modulation. Molecules 25:63\u201363","journal-title":"Molecules"},{"key":"896_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.29.21264298","author":"E Consolaro","year":"2021","unstructured":"Consolaro E, Suter F, Rubis N, Pedroni S, Moroni C, Past\u00f2 E et al (2021) A home-treatment algorithm based on anti-inflammatory drugs to prevent hospitalization of patients with early covid-19. medRxiv. https:\/\/doi.org\/10.1101\/2021.09.29.21264298","journal-title":"MedRxiv"},{"key":"896_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10495-021-01656-2","volume":"26","author":"A Donia","year":"2021","unstructured":"Donia A, Bokhari H (2021) Apoptosis induced by SARS-CoV-2: can we target it? Apoptosis 26:7\u20138","journal-title":"Apoptosis"},{"key":"896_CR11","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S2665-9913(21)00104-1","volume":"3","author":"TM Drake","year":"2021","unstructured":"Drake TM, Fairfield CJ, Pius R, Knight SR, Norman L, Girvan M et al (2021) Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol 3:e498\u2013e506","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"896_CR12","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3390\/molecules26102917","volume":"26","author":"S Fakhri","year":"2021","unstructured":"Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sanchez E et al (2021) Targeting multiple signal transduction pathways of sars-CoV-2: approaches to COVID-19 therapeutic candidates. Molecules 26(10):2917","journal-title":"Molecules"},{"key":"896_CR13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/joim.13205","volume":"289","author":"B Flam","year":"2021","unstructured":"Flam B, Wintzell V, Ludvigsson JF, M\u00e5rtensson J, Pasternak B (2021) Direct oral anticoagulant use and risk of severe COVID-19. J Intern Med 289:411\u2013419","journal-title":"J Intern Med"},{"key":"896_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11239-018-1764-5","volume":"47","author":"P Gurbel","year":"2019","unstructured":"Gurbel P, Tantry U, Weisman S (2019) A narrative review of the cardiovascular risks associated with concomitant aspirin and NSAID use. J Thromb Thrombolysis 47:16\u201330","journal-title":"J Thromb Thrombolysis"},{"key":"896_CR15","first-page":"230","volume":"47","author":"M Hiroi","year":"2005","unstructured":"Hiroi M, Ohmori Y (2005) Transcriptional synergism between NF-\u03baB and STAT1. J Oral Biosci 47:230\u2013242","journal-title":"J Oral Biosci"},{"key":"896_CR16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","volume":"100","author":"I Ikonomidis","year":"1999","unstructured":"Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P (1999) Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100:793\u2013798","journal-title":"Circulation"},{"key":"896_CR17","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1073\/pnas.1819156116","volume":"116","author":"A Kasirer-Friede","year":"2019","unstructured":"Kasirer-Friede A, Tjahjono W, Eto K, Shattil SJ (2019) SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets. Proc Natl Acad Sci U S A 116:4983\u20134988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"896_CR18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10787-020-00755-x","volume":"28","author":"MT Kelleni","year":"2020","unstructured":"Kelleni MT (2020a) ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror. Inflammopharmacology 28:1477\u20131480","journal-title":"Inflammopharmacology"},{"issue":"157","key":"896_CR19","doi-asserted-by":"publisher","first-page":"104874","DOI":"10.1016\/j.phrs.2020.104874","volume":"2020","author":"MT Kelleni","year":"2020","unstructured":"Kelleni MT (2020b) Nitazoxanide\/azithromycin combination for COVID-19: A suggested new protocol for early management. Pharmacol Res 2020(157):104874. https:\/\/doi.org\/10.1016\/j.phrs.2020.104874 (Epub 2020 Apr 30. PMID: 32360581; PMCID: PMC7192107)","journal-title":"Pharmacol Res"},{"key":"896_CR20","doi-asserted-by":"crossref","first-page":"110982","DOI":"10.1016\/j.biopha.2020.110982","volume":"133","author":"MT Kelleni","year":"2021","unstructured":"Kelleni MT (2021a) Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes. Biomed Pharmacother 133:110982","journal-title":"Biomed Pharmacother"},{"key":"896_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/1478721020211939683","author":"MT Kelleni","year":"2021","unstructured":"Kelleni MT (2021b) NSAIDs\/Nitazoxanide\/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects. Expert Rev Anti Infect Ther. https:\/\/doi.org\/10.1080\/1478721020211939683","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"896_CR22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12026-021-09219-y","volume":"69","author":"MT Kelleni","year":"2021","unstructured":"Kelleni MT (2021c) COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators. Immunol Res 69(5):457\u2013460","journal-title":"Immunol Res"},{"issue":"3","key":"896_CR23","first-page":"121","volume":"3","author":"MT Kelleni","year":"2021","unstructured":"Kelleni MT (2021d) NSAIDs\/Nitazoxanide\/azithromycin immunomodulatory protocol used in adult, geriatric, pediatric, pregnant, and immunocompromised COVID-19 patients: a real-world experience. Can J Med 3(3):121\u2013143","journal-title":"Can J Med"},{"key":"896_CR24","doi-asserted-by":"crossref","first-page":"111626","DOI":"10.1016\/j.biopha.2021.111626","volume":"139","author":"MT Kelleni","year":"2021","unstructured":"Kelleni MT (2021e) Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy. Biomed Pharmacother 139:111626","journal-title":"Biomed Pharmacother"},{"key":"896_CR25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s42399-021-00824-4","volume":"3","author":"MT Kelleni","year":"2021","unstructured":"Kelleni MT (2021f) Tocilizumab, remdesivir, favipiravir, and dexamethasone repurposed for COVID-19: a comprehensive clinical and pharmacovigilant reassessment. SN Compr Clin Med 3:919\u2013923","journal-title":"SN Compr Clin Med"},{"key":"896_CR26","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.21873\/invivo.11956","volume":"34","author":"A K\u00d6Seler","year":"2020","unstructured":"K\u00d6Seler A, Sabirli R, G\u00d6ren T, T\u00dcrk\u00e7\u00dcEr \u0130, Kurt \u00d6 (2020) Endoplasmic reticulum stress markers in SARS-COV-2 infection and pneumonia: case-control study. In Vivo 34:1645","journal-title":"In Vivo"},{"key":"896_CR27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10787-021-00810-1","volume":"29","author":"CS Kow","year":"2021","unstructured":"Kow CS, Hasan SS (2021) The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology 29:641\u2013644","journal-title":"Inflammopharmacology"},{"key":"896_CR28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-020-00334-0","volume":"5","author":"S Li","year":"2020","unstructured":"Li S, Zhang Y, Guan Z, Li H, Ye M, Chen X et al (2020) SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct Target Ther 5:235","journal-title":"Signal Transduct Target Ther"},{"key":"896_CR29","doi-asserted-by":"crossref","first-page":"173748","DOI":"10.1016\/j.ejphar.2020.173748","volume":"891","author":"AS Lokhande","year":"2021","unstructured":"Lokhande AS, Devarajan PV (2021) A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. Eur J Pharmacol 891:173748","journal-title":"Eur J Pharmacol"},{"key":"896_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2021.09.009","author":"SH Manjunath","year":"2021","unstructured":"Manjunath SH, Thimmulappa RK (2021) Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19. J Pharm Anal. https:\/\/doi.org\/10.1016\/j.jpha.2021.09.009","journal-title":"J Pharm Anal"},{"key":"896_CR31","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3855\/jidc.13274","volume":"14","author":"J Meneses Calderon","year":"2020","unstructured":"Meneses Calderon J, Figueroa Flores MDR, Paniagua Coria L, Briones Garduno JC, Meneses Figueroa J, Vargas Contretas MJ et al (2020) Nitazoxanide against COVID-19 in three explorative scenarios. J Infect Dev Ctries 14:982\u2013986","journal-title":"J Infect Dev Ctries"},{"key":"896_CR32","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40264-021-01089-5","volume":"44","author":"N Moore","year":"2021","unstructured":"Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C (2021) NSAIDs and COVID-19: a systematic review and meta-analysis. Drug Saf 44:929\u2013938","journal-title":"Drug Saf"},{"issue":"23","key":"896_CR33","volume":"95","author":"E Nilsson-Payant Benjamin","year":"2021","unstructured":"Nilsson-Payant Benjamin E, Uhl S, Grimont A, Doane Ashley S, Cohen P, Patel Roosheel S et al (2021) The NF-\u03baB transcriptional footprint is essential for SARS-CoV-2 replication. J Virol 95(23):e0125721","journal-title":"J Virol"},{"key":"896_CR34","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.bbrc.2018.08.078","volume":"503","author":"T Omura","year":"2018","unstructured":"Omura T, Sasaoka M, Hashimoto G, Imai S, Yamamoto J, Sato Y et al (2018) Oxicam-derived non-steroidal anti-inflammatory drugs suppress 1-methyl-4-phenyl pyridinium-induced cell death via repression of endoplasmic reticulum stress response and mitochondrial dysfunction in SH-SY5Y cells. Biochem Biophys Res Commun 503:2963\u20132969","journal-title":"Biochem Biophys Res Commun"},{"key":"896_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13650","author":"S Pandolfi","year":"2021","unstructured":"Pandolfi S, Chirumbolo S (2021) Home therapy of COVID-19 at the earliest may greatly prevent hospitalization. Basic Clin Pharmacol Toxicol. https:\/\/doi.org\/10.1111\/bcpt.13650","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"896_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/SHK.0000000000000745","volume":"47","author":"BA Panka","year":"2017","unstructured":"Panka BA, de Grooth H-J, Spoelstra-de Man AME, Looney MR, Tuinman P-R (2017) Prevention or treatment of Ards with aspirin: a review of preclinical models and meta-analysis of clinical studies. Shock 47:13\u201321","journal-title":"Shock"},{"key":"896_CR37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","volume":"76","author":"I Paranjpe","year":"2020","unstructured":"Paranjpe I, Fuster V, Lala A, Russak AJ, Glicksberg BS, Levin MA et al (2020) Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol 76:122\u2013124","journal-title":"J Am Coll Cardiol"},{"key":"896_CR38","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S2213-2600(21)00379-9","volume":"9","author":"J Patel","year":"2021","unstructured":"Patel J, Berezowski I, Abdelmonem A, Taylor D, Pourmand A (2021) Azithromycin for mild-to-moderate COVID-19. Lancet Respir Med 9:e99","journal-title":"Lancet Respir Med"},{"key":"896_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.02.20223636","author":"M Plassmeyer","year":"2020","unstructured":"Plassmeyer M, Alpan O, Corley MJ, Lillard K, Coatney P, Vaziri T et al (2020) Caspases in COVID-19 disease and sequela and the therapeutic potential of caspase inhibitors. medRxiv. https:\/\/doi.org\/10.1101\/2020.11.02.20223636","journal-title":"medRxiv"},{"key":"896_CR40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41423-020-0485-9","volume":"17","author":"Y Ren","year":"2020","unstructured":"Ren Y, Shu T, Wu D, Mu J, Wang C, Huang M et al (2020) The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell Mol Immunol 17:881\u2013883","journal-title":"Cell Mol Immunol"},{"key":"896_CR41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349\u2013361","journal-title":"Nat Rev Immunol"},{"key":"896_CR42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10787-020-00745-z","volume":"28","author":"L Smart","year":"2020","unstructured":"Smart L, Fawkes N, Goggin P, Pennick G, Rainsford KD, Charlesworth B et al (2020) A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality. Inflammopharmacology 28:1141\u20131152","journal-title":"Inflammopharmacology"},{"key":"896_CR43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.chembiol.2017.02.003","volume":"24","author":"CE Smith","year":"2017","unstructured":"Smith CE, Soti S, Jones TA, Nakagawa A, Xue D, Yin H (2017) Non-steroidal anti-inflammatory drugs are caspase inhibitors. Cell Chem Biol 24:281\u2013292","journal-title":"Cell Chem Biol"},{"key":"896_CR44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pbj.2017.05.005","volume":"2","author":"O Sonmez","year":"2017","unstructured":"Sonmez O, Sonmez M (2017) Role of platelets in immune system and inflammation. Porto Biomed J 2:311\u2013314","journal-title":"Porto Biomed J"},{"key":"896_CR45","doi-asserted-by":"crossref","first-page":"108863","DOI":"10.1016\/j.celrep.2021.108863","volume":"34","author":"EA Thompson","year":"2021","unstructured":"Thompson EA, Cascino K, Ordonez AA, Zhou W, Vaghasia A, Hamacher-Brady A et al (2021) Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep 34:108863","journal-title":"Cell Rep"},{"key":"896_CR46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12471-021-01574-7","volume":"29","author":"RG Tieleman","year":"2021","unstructured":"Tieleman RG, Klok FA, Belfroid E, Hoogervorst-Schilp J, Schalkers I, Jansen CW et al (2021) Effect of anticoagulant therapy in COVID-19 patients. Neth Heart J 29:35\u201344","journal-title":"Neth Heart J"},{"key":"896_CR47","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.immuni.2019.05.020","volume":"50","author":"N Van Opdenbosch","year":"2019","unstructured":"Van Opdenbosch N, Lamkanfi M (2019) Caspases in cell death, inflammation, and disease. Immunity 50:1352\u20131364","journal-title":"Immunity"},{"key":"896_CR48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","volume":"72","author":"TD Warner","year":"2011","unstructured":"Warner TD, Nylander S, Whatling C (2011) Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol 72:619\u2013633","journal-title":"Br J Clin Pharmacol"},{"key":"896_CR49","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/ddr.21801","volume":"82","author":"YW Xing","year":"2021","unstructured":"Xing YW, Liu KZ (2021) Azithromycin inhibited oxidative stress and apoptosis of high glucose-induced podocytes by inhibiting STAT1 pathway. Drug Dev Res 82:990\u2013998","journal-title":"Drug Dev Res"},{"key":"896_CR50","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.neuropharm.2005.10.016","volume":"50","author":"T Yamazaki","year":"2006","unstructured":"Yamazaki T, Muramoto M, Oe T, Morikawa N, Okitsu O, Nagashima T et al (2006) Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling. Neuropharmacology 50:558\u2013567","journal-title":"Neuropharmacology"},{"key":"896_CR51","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbagen.2008.07.009","volume":"1780","author":"Z Ye","year":"2008","unstructured":"Ye Z, Wong CK, Li P, Xie Y (2008) A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis. Biochim Biophys Acta 1780:1383\u20131387","journal-title":"Biochim Biophys Acta"},{"key":"896_CR52","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3903939","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Zhao S, Gan L, Wang Z, Peng S, Li Q et al (2021) Associations between the use of non-steroidal anti-inflammatory drugs and adverse outcomes among patients with COVID-19: a systematic review and meta-analysis. SSRN. https:\/\/doi.org\/10.2139\/ssrn.3903939","journal-title":"SSRN"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00896-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-021-00896-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00896-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T11:22:55Z","timestamp":1646997775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-021-00896-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1007\/s10787-021-00896-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"26 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}